Tun daga shekarar 2024, mun lura cewa ƙasashe da yankuna a faɗin duniya sun gabatar da jerin takunkumi, ƙuntatawa, tsawaita lokacin amincewa, ko sake duba shawarwari kan nau'ikan sinadarai masu aiki da magungunan kashe kwari. Wannan takarda ta tsara kuma ta rarraba yanayin ƙuntatawa na magungunan kashe kwari a duniya a rabin farko na 2024, domin samar da ma'ana ga kamfanonin magungunan kashe kwari don tsara dabarun magance su, da kuma taimaka wa kamfanoni su tsara da kuma adana wasu samfuran a gaba, don ci gaba da kasancewa masu gasa a kasuwar da ke canzawa.
An haramta
(1) Ester mai kunnawa
A watan Yunin 2024, Tarayyar Turai ta fitar da Sanarwa (EU) 2024/1696 don janye shawarar amincewa ga Activated esters of Active substances (Acibenzolar-S-methyl) da kuma sabunta Jerin Abubuwan Aiki da aka Amince da su (EU) Lamba 540/2011.
A watan Satumba na 2023, mai neman aikin ya sanar da Hukumar Turai cewa saboda an dakatar da binciken da ta yi kan kaddarorin da ke kawo cikas ga endocrine na esters masu aiki kuma an sanya sinadarin a matsayin mai guba ga haihuwa a Rukunin 1B a ƙarƙashin Dokar Rarrabawa, Lakabi da Marufi ta EU (CLP), ba ta cika sharuɗɗan amincewar EU na magungunan kashe kwari ba. Ƙasashen Membobi za su janye izini ga samfuran da ke ɗauke da esters masu aiki a matsayin sinadarai masu aiki kafin 10 ga Janairu 2025, kuma duk wani lokacin canji da aka bayar a ƙarƙashin Mataki na 46 na Dokar Kashe Kwari ta EU zai ƙare a ranar 10 ga Yuli 2025.
(2) Tarayyar Turai ba za ta sabunta amincewar enoylmorpholine ba
A ranar 29 ga Afrilu 2024, Hukumar Tarayyar Turai ta buga Dokar (EU) 2024/1207 kan rashin sabunta amincewa da sinadarin diformylmorpholine mai aiki. Ganin cewa Tarayyar Turai ba ta sabunta amincewarta da DMM a matsayin sinadari mai aiki a cikin kayayyakin kare tsirrai ba, ana buƙatar Ƙasashen Membobi su janye kayayyakin fungi da ke ɗauke da wannan sinadari, kamar Orvego®, Forum® da Forum® Gold, kafin 20 ga Nuwamba 2024. A lokaci guda, kowace Ƙasa ta memba ta sanya wa'adin sayarwa da amfani da kayayyakin har zuwa 20 ga Mayu, 2025.
A ranar 23 ga Yuni, 2023, Hukumar Kula da Abinci ta Turai (EFSA) ta bayyana karara a cikin rahotonta na kimanta haɗari da ta buga a bainar jama'a cewa enoylmorpholine yana da babban haɗari na dogon lokaci ga dabbobi masu shayarwa kuma an rarraba shi a matsayin guba ta haihuwa ta rukuni na 1B kuma ana ɗaukarsa a matsayin mai kawo cikas ga tsarin endocrine na dabbobi masu shayarwa. Ganin haka, tare da dakatar da amfani da enylmorpholine a Tarayyar Turai, mahaɗan yana fuskantar yiwuwar haramta shi gaba ɗaya.
(3) Tarayyar Turai ta haramta sinadarin spermatachlor a hukumance
A ranar 3 ga Janairu, 2024, Hukumar Tarayyar Turai (EC) ta yanke shawara a hukumance: bisa ga Dokar Kare Shuke-shuke ta EU (EC) Lamba 1107/2009, ba a sake amincewa da sinadarin spermine metolachlor (S-metolachlor) don yin rijistar kayayyakin kariya daga tsirrai na EU ba.
Tarayyar Turai ta fara amincewa da Metolachlor a shekarar 2005. A ranar 15 ga Fabrairu, 2023, Hukumar Lafiya da Tsaro ta Faransa (ANSES) ta ba da umarnin hana amfani da wasu magungunan metolachlor kuma tana shirin janye izinin amfani da manyan kayayyakin kariya daga tsirrai da ke dauke da sinadarin metolachlor domin kare albarkatun ruwan karkashin kasa. A ranar 24 ga Mayu, 2023, Hukumar Tarayyar Turai ta gabatar wa WTO da wata sanarwa (daftarin) kan janye amincewar sinadarin spermatalachlor mai aiki. A cewar sanarwar da Tarayyar Turai ta bayar ga WTO, shawarar da aka bayar a baya ta tsawaita lokacin inganci (har zuwa 15 ga Nuwamba, 2024) ba za ta yi aiki ba.
(4) An haramta nau'ikan magungunan kashe kwari guda 10 kamar carbendazim da acephamidophos a Punjab, Indiya
A watan Maris na 2024, jihar Punjab ta Indiya ta sanar da cewa za ta haramta sayarwa, rarrabawa da amfani da magungunan kashe kwari guda 10 masu yawan gaske (acephamidophos, thiazone, chlorpyrifos, hexazolol, propiconazole, thiamethoxam, propion, imidacloprid, carbendazim da tricyclozole) da duk wani tsari na waɗannan magungunan kashe kwari a jihar daga ranar 15 ga Yuli, 2024. Wannan lokaci na kwanaki 60 an yi shi ne don kare ingancin kayayyaki da kuma cinikin shinkafar Basmati ta musamman da ake fitarwa daga ƙasashen waje.
An ruwaito cewa shawarar ta samo asali ne saboda fargabar cewa wasu magungunan kashe kwari a cikin ragowar shinkafar Basmati sun wuce ka'ida. A cewar Kungiyar Masu Fitar da Shinkafa ta jihar, ragowar magungunan kashe kwari a cikin samfuran shinkafa masu ƙamshi da yawa sun wuce iyakar iyakar ragowar, wanda ka iya shafar cinikin fitar da su daga ƙasashen waje.
(5) An haramta amfani da Atrazine, nitrosulfamone, tert-butylamine, promethalachlor da flursulfametamamide a Myanmar
A ranar 17 ga Janairu, 2024, Ofishin Kare Shuke-shuke (PPD) na Ma'aikatar Noma ta Myanmar ya fitar da sanarwa yana sanar da kawar da atrazine, mesotrione, Terbuthylazine, S-metolachlor, An ƙara nau'ikan maganin kashe kwari guda biyar na Fomesafen a cikin jerin da aka haramta a Myanmar, tare da haramcin ya fara daga 1 ga Janairu, 2025.
A cewar sanarwar, nau'ikan magungunan kashe kwari guda biyar da aka haramta, wadanda suka sami takaddun shaida na kamfanoni masu dacewa, za su iya ci gaba da neman izinin lasisin shigo da su kafin 1 ga Yuni, 2024 ga PPD, sannan kuma ba za su sake samun sabbin aikace-aikacen amincewa da lasisin shigo da su ba, gami da an gabatar da rajistar da ta shafi nau'ikan da ke sama.
Haramcin da aka yi niyya
(1) Hukumar Kare Muhalli ta Amurka ta ba da shawarar haramta acephate kuma a ci gaba da amfani da bishiyoyi kawai don allura
A watan Mayun 2024, Hukumar Kare Muhalli ta Amurka (EPA) ta fitar da daftarin shawara na wucin gadi (PID) kan acephate, inda ta yi kira da a kawar da duk wani amfani da sinadarin sai dai sau ɗaya kawai. Hukumar EPA ta lura cewa wannan shawara ta dogara ne akan daftarin da aka sabunta na Kimanta Hadarin Lafiyar Dan Adam da kimanta ruwan sha na watan Agustan 2023, wanda ya bayyana yuwuwar samun manyan haɗarin abinci daga amfani da acephate a cikin ruwan sha da aka yi rijista a halin yanzu.
Duk da cewa shawarar da EPA ta gabatar na Preliminary Determination (PID) don acephate ta ba da shawarar kawar da yawancin amfani da shi, an ci gaba da amfani da maganin kwari don allurar bishiyoyi. EPA ta ce wannan aikin ba ya ƙara haɗarin kamuwa da ruwan sha, ba ya haifar da haɗari ga ma'aikata kuma, ta hanyar canza lakabin, ba ya haifar da barazana ga muhalli. EPA ta jaddada cewa allurar bishiyoyi tana ba da damar kwari su ratsa bishiyoyi kuma su shawo kan kwari yadda ya kamata, amma ga bishiyoyin da ba sa samar da 'ya'ya don amfanin ɗan adam.
(2) Birtaniya na iya haramta mancozeb
A watan Janairun 2024, Hukumar Kula da Lafiya da Tsaro ta Burtaniya (HSE) ta gabatar da shawarar janye amincewa da mancozeb, sinadarin da ke aiki a cikin magungunan kashe ƙwayoyin cuta.
Dangane da cikakken nazari kan sabbin shaidu da bayanai da UPL da Indofil Industries suka gabatar dangane da mancozeb, bisa ga Mataki na 21 na Dokar (EC) 1107/2009 da Tarayyar Turai ta riƙe, HSE ta kammala da cewa mancozeb ba ya cika sharuɗɗan da ake buƙata don amincewa. Musamman game da halayen endocrine da ke kawo cikas ga yanayin jiki da haɗarin kamuwa da cuta. Wannan ƙarshe na iya haifar da manyan canje-canje a amfani da mancozeb a Burtaniya. Amincewar mancozeb a Burtaniya ta ƙare a ranar 31 ga Janairu 2024 kuma HSE ta nuna cewa za a iya tsawaita wannan amincewa na ɗan lokaci na tsawon watanni uku, gwargwadon tabbatarwa.
Ƙuntata
(1) Canje-canje ga Hukumar Kare Muhalli ta Amurka ga manufofin chlorpyrifos: Umarnin sokewa, gyare-gyaren ƙa'idojin kaya, da ƙuntatawa na amfani
A watan Yunin 2024, Hukumar Kare Muhalli ta Amurka (EPA) kwanan nan ta ɗauki wasu matakai masu mahimmanci don magance haɗarin lafiya da muhalli na ƙwayoyin cuta na organophosphorus chlorpyrifos. Wannan ya haɗa da umarnin sokewa na ƙarshe na samfuran chlorpyrifos da sabuntawa ga ƙa'idodin kaya da ake da su.
An taɓa amfani da Chlorpyrifos sosai a kan nau'ikan amfanin gona daban-daban, amma EPA ta janye iyakokinta na abinci da abincin dabbobi a watan Agusta na 2021 saboda barazanar da ke tattare da shi ga lafiya. Wannan shawarar ta zo ne a matsayin martani ga umarnin kotu na gaggauta magance amfani da chlorpyrifos. Duk da haka, wata Kotun Daukaka Kara ta soke hukuncin kotun a watan Disamba na 2023, wanda ya sa EPA ta sabunta manufofinta don nuna hukuncin.
A cikin sabunta manufofin, samfurin chlorpyrifos na Cordihua Dursban 50W a cikin Fakitin Ruwa Mai Narkewa ya fuskanci sokewa da son rai, kuma duk da ra'ayoyin jama'a, EPA a ƙarshe ta amince da buƙatar sokewa. Samfurin chlorpyrifos na Gharda na Indiya shi ma yana fuskantar sokewa da amfani, amma yana ci gaba da amfani da takamaiman amfanin gona 11. Bugu da ƙari, an soke samfuran chlorpyrifos na Liberty da Winfield da son rai, amma an tsawaita lokacin sayarwa da rarraba hannun jarinsu na yanzu har zuwa 2025.
Ana sa ran Hukumar EPA za ta fitar da dokoki da aka tsara daga baya a wannan shekarar don ƙara takaita amfani da sinadarin chlorpyrifos, wanda zai rage yawan amfani da shi a Amurka sosai.
(2) Tarayyar Turai ta sake duba sharuɗɗan amincewa da Metalaxyl, kuma an sassauta iyakokin ƙazanta masu alaƙa da hakan
A watan Yunin 2024, Tarayyar Turai ta fitar da sanarwar (EU) ta 2024/1718 wadda ta gyara sharuɗɗan amincewa da Metalaxylin, wanda ya sassauta iyakokin ƙazanta masu dacewa, amma ya riƙe ƙuntatawa da aka ƙara bayan bita na 2020 - lokacin da aka yi amfani da shi don maganin iri, ana iya yin maganin ne kawai akan tsaba daga baya aka shuka a cikin gidajen kore. Bayan sabuntawa, yanayin amincewa da metalaxyl shine: abu mai aiki ≥ 920 g/kg. Tsatsa masu alaƙa 2,6-dimethylphenylamine: matsakaicin abun ciki: 0.5 g/kg; 4-methoxy-5-methyl-5H-[1,2]oxathiole 2,2 dioxide: matsakaicin abun ciki: 1 g/kg; 2-[(2,6-dimethyl-phenyl)-(2-methoxyacetyl)-amino]-propionic acid 1-methoxycarbonyl-ethyl ester: matsakaicin abun ciki<10 g/kg
(3) Ostiraliya ta sake duba cutar malathion kuma ta sanya ƙarin takunkumi
A watan Mayu na 2024, Hukumar Kula da Magungunan Kashe Kwayoyin Cuku da Dabbobi ta Ostiraliya (APVMA) ta fitar da shawararta ta ƙarshe kan sake duba magungunan kwari na Malathion, wanda zai sanya ƙarin ƙuntatawa a kansu - canza da kuma tabbatar da amincewar sinadaran aiki na Malathion, rajistar samfura da kuma amincewar lakabi da ke da alaƙa, gami da: Canza sunan sinadaran aiki daga "maldison" zuwa "malathion" don ya yi daidai da sunan da aka ƙayyade a cikin ISO 1750: 1981; Hana amfani kai tsaye a cikin ruwa saboda haɗarin nau'ikan ruwa da kuma kawar da amfani da tsutsotsi na sauro; Sabunta umarnin amfani, gami da ƙuntatawa na amfani, ma'ajiyar feshi, lokacin cirewa, umarnin aminci, da yanayin ajiya; Duk samfuran da ke ɗauke da malathion dole ne su sami ranar ƙarewa kuma su nuna ranar ƙarewa daidai akan lakabin.
Domin sauƙaƙa sauyin, APVMA za ta ba da lokacin ƙarewa na shekaru biyu, wanda a lokacin ne kayayyakin Malathion masu tsohon lakabin za su iya yaɗuwa, amma dole ne a yi amfani da sabon lakabin bayan ƙarewar.
(4) Amurka ta sanya takamaiman takunkumi a fannin amfani da chlorpyrifos, diazinphos, da malathion
A watan Afrilun 2024, Hukumar Kare Muhalli ta Amurka (EPA) ta sanar da cewa za ta sanya takamaiman iyaka kan amfani da magungunan kashe kwari masu suna chlorpyrifos, diazinphos, da malathion don kare nau'ikan da ke fuskantar barazana ko barazanar fuskantar barazanar tsaro da kuma muhimman wuraren zama, da sauran matakai, ta hanyar sauya buƙatun lakabin magungunan kashe kwari da kuma fitar da sanarwar kare nau'ikan da ke fuskantar barazanar tsaro.
Sanarwar ta yi bayani dalla-dalla kan lokutan amfani, yawan amfani, da kuma ƙuntatawa kan haɗawa da wasu magungunan kashe ƙwari. Musamman ma, amfani da chlorpyrifos da diazinphos shi ma yana ƙara iyakokin saurin iska, yayin da amfani da malathion yana buƙatar yankunan kariya tsakanin wuraren amfani da su da kuma wuraren zama masu laushi. Waɗannan matakan rage tasirin suna da nufin kariya biyu: tabbatar da cewa an kare nau'ikan da aka lissafa daga lahani yayin da kuma rage yuwuwar tasirin da zai iya yi wa nau'ikan da ba a lissafa ba.
(5) Ostiraliya ta sake kimanta maganin kwaridiazinphos, ko kuma zai ƙara tsaurara ikon amfani da shi
A watan Maris na 2024, Hukumar Kula da Magungunan Dabbobi da Magungunan Dabbobi ta Ostiraliya (APVMA) ta fitar da shawarar sake tantance amfani da maganin kwari mai faɗi-faɗi na diazinphos ta hanyar sake duba duk sinadaran aiki na diazinphos da ke akwai da kuma amincewar rajistar samfura da lakabin da suka shafi su. APVMA tana shirin riƙe aƙalla hanyar amfani guda ɗaya yayin da take cire amincewa da suka dace waɗanda ba su cika sharuɗɗan aminci, ciniki ko lakabin doka ba. Haka kuma za a sabunta ƙarin sharuɗɗa don sauran amincewar sinadaran aiki.
(6) Majalisar Tarayyar Turai ta haramta shigo da abinci daga ƙasashen waje wanda ke ɗauke da ragowar thiacloprid
A watan Janairun 2024, Majalisar Tarayyar Turai ta yi watsi da shawarar Hukumar Tarayyar Turai ta "ba da izinin shigo da kayayyaki sama da 30 da ke ɗauke da ragowar maganin kwari na thiacloprid." Kin amincewa da shawarar yana nufin cewa iyakar ragowar thiacloprid (MRL) a cikin abincin da aka shigo da shi za a kiyaye shi a matakin sifili. A bisa ga ƙa'idodin Tarayyar Turai, MRL shine matsakaicin matakin ragowar magungunan kwari da aka yarda da shi a cikin abinci ko abinci, lokacin da Tarayyar Turai ta hana maganin kwari, MRL na sinadarin da ke kan kayayyakin da aka shigo da su an saita shi zuwa 0.01mg/kg, wato, sifili ragowar maganin asali.
Thiacloprid wani sabon maganin kwari ne mai sinadarin chlorine wanda za a iya amfani da shi sosai a kan amfanin gona da yawa don magance kwari masu cizon baki da kuma tauna bakinsu, amma saboda tasirinsa ga ƙudan zuma da sauran masu yin fure, an takaita shi a hankali a Tarayyar Turai tun daga shekarar 2013.
Dage haramcin
(1) An sake ba da izinin sayarwa, amfani, samarwa da shigo da Thiamethoxam a Brazil
A watan Mayu na shekarar 2024, Kotun Farko ta Gundumar Tarayya ta Brazil ta yanke shawarar ɗage takunkumi kan sayarwa, amfani, samarwa ko shigo da kayayyakin thiamethoxam masu ɗauke da sinadarai a Brazil. Wannan shawarar ta sauya sanarwar da Cibiyar Muhalli da Albarkatun Kasa Mai Sabuntawa ta Brazil (Ibama) ta fitar a watan Fabrairu na hana amfani da kayayyakin.
Ana iya tallata kayayyakin da ke ɗauke da thiamethoxam kuma ana ba da shawarar a sake amfani da su bisa ga umarnin da ke kan lakabin. Tare da sabon ƙudurin, an sake ba wa masu rarrabawa, ƙungiyoyin haɗin gwiwa da dillalai izinin bin shawarwarin don tallata kayayyakin da ke ɗauke da thiamethoxam, kuma manoman Brazil za su iya ci gaba da amfani da irin waɗannan samfuran idan ƙwararrun ma'aikata suka umarce su da su bi lakabin da shawarwarin.
Ci gaba
(1) Mexico ta sake dage haramcin amfani da glyphosate
A watan Maris na 2024, gwamnatin Mexico ta sanar da cewa za a jinkirta haramcin amfani da magungunan kashe kwari masu dauke da glyphosate, wadanda aka tsara aiwatarwa a farkon watan Maris, har sai an sami wasu hanyoyin da za su ci gaba da samar da amfanin gona.
A cewar wata sanarwa da gwamnati ta fitar, dokar shugaban kasa ta watan Fabrairun 2023 ta tsawaita wa'adin haramta amfani da glyphosate har zuwa ranar 31 ga Maris, 2024, idan aka yi la'akari da samuwar wasu hanyoyin. "Yayin da har yanzu ba a cimma sharuddan maye gurbin glyphosate a fannin noma ba, dole ne a ci gaba da kare lafiyar abinci a kasar," in ji sanarwar, ciki har da wasu sinadarai na noma wadanda ke da aminci ga lafiya da kuma hanyoyin dakile ciyawa wadanda ba sa bukatar amfani da magungunan kashe kwari.
(2) Hukumar Kare Muhalli ta Amurka ta bayar da umarnin kayyayaki domin tabbatar da ci gaba da amfani da kayayyakin alkama a cikin tashar
A watan Fabrairun 2024, Kotun Gundumar Arizona ta Amurka ta soke izinin da BASF, Bayer da Syngenta suka bayar na fesawa kai tsaye a saman tsirrai don amfani da su ta hanyar amfani da Engenia, XtendiMax da Tavium (ba tare da amfani da su ba).
Domin tabbatar da cewa hanyoyin kasuwanci ba su da matsala, Hukumar Kare Muhalli ta Amurka ta bayar da Umarnin Hannun Jari na lokacin noman 2024, wanda ke tabbatar da amfani da trimoxil a lokutan noman waken soya da auduga na 2024. Dokar Hannun Jari ta Yanzu ta bayyana cewa kayayyakin primovos da suka riga suka kasance a hannun masu rarrabawa, ƙungiyoyin haɗin gwiwa da sauran ɓangarori kafin 6 ga Fabrairu, za a sayar da su kuma a rarraba su a cikin jagororin da aka tsara a cikin umarnin, gami da manoman da suka sayi primovos kafin 6 ga Fabrairu, 2024.
(3) Tarayyar Turai ta tsawaita lokacin amincewa ga dozin abubuwa masu aiki
A ranar 19 ga Janairu, 2024, Hukumar Tarayyar Turai ta fitar da Dokar (EU) mai lamba 2024/324, inda ta tsawaita lokacin amincewa da sinadarai 13 masu aiki, ciki har da fluoroamides. Bisa ga ƙa'idodin, an tsawaita lokacin amincewa da ingantaccen 2-methyl-4-chloropropionic acid (Mecoprop-P) har zuwa 15 ga Mayu, 2025. An tsawaita lokacin amincewa da Flutolanil zuwa 15 ga Yuni, 2025. An tsawaita lokacin amincewa da Pyraclostrobin zuwa 15 ga Satumba, 2025. An tsawaita lokacin amincewa da Mepiquat zuwa 15 ga Oktoba, 2025. An tsawaita lokacin amincewa da thiazinone (Buprofezin) har zuwa 15 ga Disamba, 2025. An tsawaita lokacin amincewa da phosphine (Phosphane) zuwa 15 ga Maris, 2026. An tsawaita lokacin amincewa da Fluazinam zuwa 15 ga Afrilu, 2026. An tsawaita lokacin amincewa da Fluopyram zuwa 30 ga Yuni, 2026. An tsawaita lokacin amincewa da Benzovindiflupyr zuwa 2 ga Agusta, 2026. Lokacin amincewa da Lambda-cyhalothrin da An tsawaita Mesulfuron-methyl zuwa 31 ga Agusta, 2026. An tsawaita lokacin amincewa da Bromuconazole zuwa 30 ga Afrilu, 2027. An tsawaita lokacin amincewa da Cyflufenamid har zuwa 30 ga Yuni, 2027.
A ranar 30 ga Afrilu, 2024, Hukumar Tarayyar Turai ta fitar da Dokar (EU) ta 2024/1206, inda ta tsawaita lokacin amincewa ga sinadarai 20 masu aiki kamar Voxuron. Bisa ga ƙa'idodin, 6-benzyladenine (6-Benzyladenine), dodine (dodine), n-decanol (1-decanol), fluometuron (fluometuron), sintofen (aluminum) sulfate An tsawaita lokacin amincewa da sulfate da prosulfuron zuwa 15 ga Yuli, 2026. Chloromequinolinic acid (quinmerac), zinc phosphide, man lemu, cyclosulfonone (tembotrione) da sodium thiosulfate (sodium azurfa) An tsawaita lokacin amincewa da thiosulfate zuwa 31 ga Disamba, 2026. tau-fluvalinate, bupirimate, isoxaben, azadirachtin, lime An tsawaita lokacin amincewa da sulfur, tebufenozide, dithianon da hexythiazox zuwa 31 ga Janairu, 2027.
Sake kimantawa
(1) US EPA sabunta Malathion sake dubawa Sabuntawa
A watan Afrilun 2024, Hukumar Kare Muhalli ta Amurka (EPA) ta sabunta daftarin kimanta haɗarin lafiyar ɗan adam game da maganin kwari na Malathion kuma ta gano babu wata barazanar lafiyar ɗan adam da ke damun ta bisa ga bayanai da ake da su da kuma yanayin da ake ciki.
A cikin wannan sake duba cutar malathion, an gano cewa (1) matakan rage haɗarin malathion sun yi tasiri ne kawai a gidajen kore; ② Malathion yana da babban haɗari ga tsuntsaye. Saboda haka, Hukumar Turai ta yanke shawarar gyara sharuɗɗan amincewa da cutar malathion don iyakance amfani da ita ga gidajen kore na dindindin.
(2) Antipour ester ya amince da sake duba yarjejeniyar EU
A watan Maris na 2024, Hukumar Tarayyar Turai (EC) ta fitar da wani kuduri na amincewa da tsawaita ingancin sinadarin trinexapac-ethyl har zuwa 30 ga Afrilu 2039. Bayan sake duba shi, an ƙara ƙayyadadden sinadarin antiretroester daga 940 g/kg zuwa 950 g/kg, kuma an ƙara ƙazanta guda biyu masu alaƙa: ethyl(1RS)-3-hydroxy-5-oxocyclohex-3-ene-1-carboxylate (ƙayyadadden ≤3 g/kg).
Hukumar Tarayyar Turai a ƙarshe ta yanke shawarar cewa paracylate ya cika sharuɗɗan amincewa a ƙarƙashin Dokar PPP don samfuran kariya daga tsirrai a cikin Tarayyar Turai, kuma ta kammala da cewa duk da cewa sake duba paracylate ya dogara ne akan ƙayyadadden adadin amfani na yau da kullun, wannan bai iyakance yiwuwar amfani da samfurin samar da shi ba, don haka ta ɗage ƙuntatawa akan amfani da shi azaman mai kula da haɓakar shuka kawai a cikin amincewar da ta gabata.
Lokacin Saƙo: Yuli-01-2024